Retatrutide needs to be dosed meticulously, because the dose should be increased progressively to attenuate Unintended effects. An average starting dose for the 1st four weeks in phase 2 trials is 2mg/week. The gradual increase in dosage should final for at least twelve weeks. Regrettably, the dosing protocols in https://travisrjvjq.isblog.net/everything-about-retatrutide-dosing-55517030